These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3904559)

  • 21. Effect of oral calcium supplementation on blood pressure in patients with previously untreated hypertension: a randomised, double-blind, placebo-controlled, crossover study.
    Galløe AM; Graudal N; Møller J; Bro H; Jørgensen M; Christensen HR
    J Hum Hypertens; 1993 Feb; 7(1):43-5. PubMed ID: 8450520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension.
    He FJ; Markandu ND; MacGregor GA
    Hypertension; 2005 Jul; 46(1):66-70. PubMed ID: 15956111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study.
    Wirell MP; Wester PO; Stegmayr BG
    J Intern Med; 1994 Aug; 236(2):189-95. PubMed ID: 7913949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
    Chrysant SG; Weder AB; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Hamilton BP; Lewin AJ; Mennella RF; Kirkegaard LW; Weir MR; Weinberger MH
    Am J Hypertens; 2000 Nov; 13(11):1180-8. PubMed ID: 11078178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Dong JY; Qin LQ; Zhang Z; Zhao Y; Wang J; Arigoni F; Zhang W
    Am Heart J; 2011 Dec; 162(6):959-65. PubMed ID: 22137067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD; Sander GE; Roffidal L; Thomas MG; Mersch DP; Moyer RR; Burris JF; Mroczek WJ; Brachfeld J
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of oral alpha-lipoic acid in overweight/obese individuals on brachial-ankle pulse wave velocity and supine blood pressure: a randomized, crossover, double-blind, placebo-controlled trial].
    Huang YD; Li N; Zhang WG; Hu XJ; Wang Q; Wang CC; Xu RW; Yan K; Hou XY; Naerkeze ; Wang XL; Yan WL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):290-6. PubMed ID: 21457668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients.
    Hazenberg BP
    Cardiology; 2000; 94(3):152-8. PubMed ID: 11279320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    Johnson BF; Frishman WH; Brobyn R; Brown RD; Reeves RL; Wombolt DG
    Am J Hypertens; 1992 Oct; 5(10):727-32. PubMed ID: 1418836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.
    Lee HY; Kim YJ; Ahn T; Youn HJ; Chull Chae S; Seog Seo H; Kim KS; Rhee MY; Choi DJ; Kim JJ; Chun KJ; Yoo BS; Park JS; Oh SK; Kim DS; Kwan J; Ahn Y; Bae Park J; Jeong JO; Hyon MS; Cho EJ; Han KR; Kim DI; Joo SJ; Shin JH; Sung KC; Jeon ES
    Clin Ther; 2015 Nov; 37(11):2581-2596.e3. PubMed ID: 25850881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension.
    Jhee SS; Salazar DE; Ford NF; Fulmor IE; Sramek JJ; Cutler NR
    Cephalalgia; 1999 Mar; 19(2):95-9. PubMed ID: 10214534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of oral calcium supplementation on blood pressure in population].
    Pan Z; Zhao L; Guo D; Yang R; Xu C; Wu X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):109-12. PubMed ID: 11860914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.